N/A N=25 AspiRATE: Novel Intervention to Acoustically Detect Silent Aspiration in Acquired Dysphagia.
Dysphagia, Oropharyngeal
Primary: Presence or Absence of Aspiration — 42 swallowing events with aspiration
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=604 A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque Psoriasis
Stable Plaque Psoriasis
Primary: Percentage of Participants With Physician's Global Assessment of Disease Severity (PGA) Score of 0 (Clear) or 1 (Almost Clear) at Day 29, With at Least a 2-point…
N/A N=36 Virtual Health Insurance Navigation Pilot Program for Colorectal Survivors
Health Insurance · Colorectal Cancer Survivors
Primary: Acceptability of the Health Insurance Navigation Program — 8.8 units on a scale
Phase 2 N=255 Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Nonalcoholic Fatty Liver Disease · Nonalcoholic Steatohepatitis With Liver Fibrosis
Primary: Mean Proportion of Participants Achieving Resolution of NASH Without Worsening/Improvement of Fibrosis by >=1 Stage Without Worsening of NASH/Both Based on Assessment by…
N/A N=396 Positive Psychology Intervention to Treat Diabetes Distress in Teens With Type 1 Diabetes
Type 1 Diabetes Mellitus
Primary: Hemoglobin A1c — 9.0; 9.0 Percentage of glycated hemoglobin
Phase 4 N=30 Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia
Tetraplegia · Hypothermia · Mild Cognitive Impairment
Primary: Change in Core Body Temperature — -0.24; -0.97; NA; 0.79 °C — p=<0.001
N/A N=450 Reducing Treatment Risk in Older Adults With Diabetes
Type 2 Diabetes Treated With Insulin · Hypoglycemia · Primary Health Care
Primary: Clinical Outcome: Number of Participants With Glycemic Regimen De-prescribing — 34; 21 Participants
N/A N=3 HYbrid RObotic Surgery in Urology
Nephrectomy
Primary: Safety of the Bitrack System — 0; 0 adverse events
Phase 3 N=10 Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT)
Multiple Myeloma
Primary: Number of Participants Categorized According to Performance Status (PS) Based on Eastern Cooperative Oncology Group (ECOG) PS — 34; 1 Participants
N/A N=416 Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)
Crohn's Disease · Ulcerative Colitis
Primary: Number of Participants With Adverse Drug Reactions — 7 Participants
Phase 2 N=6 Risperidone for the Treatment of Huntington's Disease Involuntary Movements
Huntington Disease · Chorea
Primary: Change From Baseline in Mean Unified Huntington's Disease (HD) Rating Scale Total Maximal Chorea (UHDRS TMC) Score — -2.4 score on a scale — p=0.27
Phase 3 N=100 Analyzing the Relationship Between Speed Propofol is Given and Low Blood Pressure
Hypotension on Induction
Primary: Patients Administered Propofol at a Slower Rate of Infusion Will Have Lower Incidence of Post Induction Hypotension Than Patients Administered Propofol at FDA Approved…
N/A N=19 Effects of Transcranial Direct Current Stimulation (tDCS) on Language
Stroke · Aphasia
Primary: Percent Correct on Picture Naming and Reading Tasks (Baseline on Items Was 0) — 49; 72; 56; 56 percentage of items correct
Phase 2 N=9 Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)
Schizophrenia Spectrum and Other Psychotic Disorders · Treatment-resistant Schizophrenia
Primary: Positive and Negative Syndrome Scale (PANSS) — 72.9 score on a scale
Phase 2 N=54 Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV
Tuberculosis · HIV
Primary: Percentage of Participants With Adverse Events of ≥ Grade 3 Severity — 38.9; 11.1; 83.3 percentage of participants